Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

June 30, 1997

Study Completion Date

December 31, 1998

Conditions
Growth Hormone Deficiency
Interventions
DRUG

Somatropin

3 microg/kg/day for the first three months.The dose was then doubled (6 microg/kg/day) for the next three-months.

DRUG

Somatropin

6 microg/kg/day for the first three months. The dose was then doubled (12 microg/kg/day) for the next three-months.

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Indianapolis

All Listed Sponsors
collaborator

University of Naples

OTHER

collaborator

University of Padova

OTHER

collaborator

University of Milan

OTHER

collaborator

University of Pisa

OTHER

lead

Eli Lilly and Company

INDUSTRY

NCT00570011 - Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients | Biotech Hunter | Biotech Hunter